| Title |
Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer
|
|---|---|
| Published in |
World Journal of Urology, June 2008
|
| DOI | 10.1007/s00345-008-0286-8 |
| Pubmed ID | |
| Authors |
Vincent Misraï, Morgan Rouprêt, Emmanuel Chartier-Kastler, Eva Comperat, Raphaële Renard-Penna, Alain Haertig, Marc-Olivier Bitker, François Richard, Pierre Conort |
| Abstract |
To assess the long term oncologic results of high-intensity focused ultrasound therapy (HIFU) as a primary and single treatment for clinically localized prostate cancer. |
Mendeley readers
The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 9% |
| Unknown | 21 | 91% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 8 | 35% |
| Student > Doctoral Student | 3 | 13% |
| Professor | 3 | 13% |
| Other | 2 | 9% |
| Professor > Associate Professor | 2 | 9% |
| Other | 4 | 17% |
| Unknown | 1 | 4% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 74% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
| Social Sciences | 1 | 4% |
| Computer Science | 1 | 4% |
| Unknown | 3 | 13% |